James V. Caruso
2023
In 2023, James V. Caruso earned a total compensation of $2M as President and Chief Executive Officer at Cellectar Biosciences, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $450,000 |
|---|---|
| Option Awards | $715,140 |
| Salary | $600,000 |
| Stock Awards | $107,582 |
| Other | $92,418 |
| Total | $1,965,140 |
Caruso received $715.1K in option awards, accounting for 36% of the total pay in 2023.
Caruso also received $450K in non-equity incentive plan, $600K in salary, $107.6K in stock awards and $92.4K in other compensation.
Rankings
In 2023, James V. Caruso's compensation ranked 526th out of 2,804 executives tracked by ExecPay. In other words, Caruso earned more than 81.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 526 out of 2,804 | 81st |
Division Manufacturing | 303 out of 1,541 | 80th |
Major group Chemicals And Allied Products | 214 out of 871 | 75th |
Industry group Drugs | 211 out of 834 | 75th |
Industry Pharmaceutical Preparations | 131 out of 599 | 78th |
Source: SEC filing on April 26, 2024.
Caruso's colleagues
We found two more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2023.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019